Literature DB >> 19843580

MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype.

Libero Santarpia1, Milena Nicoloso, George A Calin.   

Abstract

Several lines of evidence indicate that tumorigenesis is a complex multistep process, and that most, if not all, cancers acquire the same set of functional capabilities during development and progression, albeit through various mechanistic strategies. Increasing data show an important role of microRNAs (miRNAs or miRs) in regulating various aspects of cancer biology. This review describes the role of microRNAs during the multiple steps that drive the progressive transformation of normal cells into highly malignant derivatives, outlining the role of microRNAs in regulating the common hallmarks of tumorigenesis: self-sufficiency in growth signals, insensitivity to antigrowth signals, abnormal apoptosis, limitless replicative potential, induction and sustained angiogenesis, and tissue invasion and metastasis. Recent evidence suggests an important role of microRNAs in the regulation of the expression of most genes regulating and coordinating a wide variety of processes in endocrine glands. We will highlight microRNAs of potential relevance to endocrine tumors and hormone-dependent cancers. Through this overview of how microRNAs regulate multiple targets and entire pathways, we will provide insight into the potential to develop new molecular microRNA-targeted therapies for endocrine tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19843580     DOI: 10.1677/ERC-09-0222

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  28 in total

1.  GAS5 functions as a ceRNA to regulate hZIP1 expression by sponging miR-223 in clear cell renal cell carcinoma.

Authors:  Xiao Dong; Chuize Kong; Xiankui Liu; Jianbin Bi; Zhenhua Li; Zeliang Li; Yuyan Zhu; Zhe Zhang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

2.  Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-κB activity and miR-16-1*.

Authors:  Hai-tao Meng; Li Zhu; Wan-mao Ni; Liang-shun You; Jie Jin; Wen-bin Qian
Journal:  Acta Pharmacol Sin       Date:  2011-03-28       Impact factor: 6.150

Review 3.  MicroRNAs in thyroid cancer.

Authors:  Albert de la Chapelle; Krystian Jazdzewski
Journal:  J Clin Endocrinol Metab       Date:  2011-08-24       Impact factor: 5.958

Review 4.  MicroRNA as a diagnostic tool in fine-needle aspiration biopsy of thyroid nodules.

Authors:  Haggi Mazeh
Journal:  Oncologist       Date:  2012-06-15

5.  Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses.

Authors:  Heba W Z Khella; Nicole M A White; Hala Faragalla; Manal Gabril; Mina Boazak; David Dorian; Bishoy Khalil; Hany Antonios; Tian Tian Bao; Maria D Pasic; R John Honey; Robert Stewart; Kenneth T Pace; Georg A Bjarnason; Michael A S Jewett; George M Yousef
Journal:  Tumour Biol       Date:  2011-11-16

Review 6.  A step-by-step microRNA guide to cancer development and metastasis.

Authors:  Georgios S Markopoulos; Eugenia Roupakia; Maria Tokamani; Evangelia Chavdoula; Maria Hatziapostolou; Christos Polytarchou; Kenneth B Marcu; Athanasios G Papavassiliou; Raphael Sandaltzopoulos; Evangelos Kolettas
Journal:  Cell Oncol (Dordr)       Date:  2017-07-26       Impact factor: 6.730

7.  MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical-pathological features and outcome.

Authors:  Francesca Galuppini; Loris Bertazza; Susi Barollo; Elisabetta Cavedon; Massimo Rugge; Vincenza Guzzardo; Diana Sacchi; Sara Watutantrige-Fernando; Federica Vianello; Caterina Mian; Gianmaria Pennelli
Journal:  Virchows Arch       Date:  2017-08-31       Impact factor: 4.064

8.  Multi-dimensional discovery of biomarker and phenotype complexes.

Authors:  Philip R O Payne; Kun Huang; Kristin Keen-Circle; Abhisek Kundu; Jie Zhang; Tara B Borlawsky
Journal:  BMC Bioinformatics       Date:  2010-10-28       Impact factor: 3.169

9.  Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4.

Authors:  Qing Bo Huang; Xin Ma; Xu Zhang; Shang Wen Liu; Qing Ai; Tao Ping Shi; Yu Zhang; Yu Gao; Yang Fan; Dong Ni; Bao Jun Wang; Hong Zhao Li; Tao Zheng
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

10.  The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review.

Authors:  Haggi Mazeh; Ido Mizrahi; Nadia Ilyayev; David Halle; Bjoern Brücher; Anton Bilchik; Mladjan Protic; Martin Daumer; Alexander Stojadinovic; Avital Itzhak; Aviram Nissan
Journal:  J Cancer       Date:  2013-03-20       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.